Obese Patients, Overweight (BMI > 25)
Conditions
Keywords
Obesity, Blood Flow Restriction, Low Intensity Exercise, Antioxidant, Muscle Power, Cross Sectional Area, Hormone Profile, Overweight
Brief summary
Participants will be selected from sedentary men aged 18-30 and over with a body mass index of 25. First, an informed consent form will be signed by the individuals. The 'International Physical Activity Questionnaire' will be applied to the participants and it will be ensured that the participants have not participated in vigorous and moderate activities and therefore are inactive or minimally active individuals. The study will consist of an intervention group and a control group, and the groups will be randomized via computer. The exclusion criteria of the study are that the participants do not have any known cardiac or pulmonary pathology and do not have any musculoskeletal disorders that will affect their participation in exercise. First, blood samples will be taken from the participants. They will be sent to the laboratory for examination of biochemical, hormonal and antioxidant parameters. Then, the muscle cross-sectional area and muscle thickness values of the rectus femoris muscle will be calculated from the participants with ultrasound measurements. After these procedures are completed, Vo2Max calculation will be performed on the participants with a cardiopulmonary exercise test. In addition, 40% of the Vo2Max value calculated in this test will be calculated and the pulse range to be used in the exercise will be determined. In the final stage, participants' strength isokinetic test and knee flexion extension strength and endurance values will be calculated. After the evaluations are completed, individuals will start a 6-week exercise program. The intervention group will exercise with the blood flow restriction method under 160 mmHg pressure for the first 3 weeks and 180 mmHg pressure for the last 3 weeks. The device will be applied by placing it at the most proximal point of the thigh. The control group will do the same exercise without restricting blood flow. Both groups will be followed for 6 weeks with a 5-minute warm-up followed by a 20-minute exercise program. Participants will report their fatigue with the Borg scale after each exercise session. After the exercise sessions are completed, blood will be taken on an empty stomach within 24 hours of the last exercise. Then, muscle size measurement with ultrasound, Vo2Max calculation and isokinetic test power calculation will be noted, respectively. The values obtained will be compared with the initial values.
Interventions
OTHERBFR-Aerobic Training
Low-intensity cycling exercise with BFR (pressure of 160-180 mmHg) for 20 minutes, 3 days a week for 6 weeks.
OTHERAerobic Training Without BFR
Low-intensity cycling exercise (without BFR) for 20 minutes, 3 days a week for 6 weeks.
Sponsors
Istanbul University Research Fund
Istanbul University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes
Inclusion criteria
Age: 18-30 Gender: Male Body Mass Index (BMI) ≥ 25 kg/m² Inactive or minimally active individuals (assessed with the International Physical Activity Questionnaire - IPAQ) No history of metabolic, cardiovascular or neuromuscular disease Not taking any medication that affects metabolism, hormones or muscle function Able to participate in a 6-week exercise program
Exclusion criteria
Having a cardiac or respiratory complaint Having a known chronic disease Having a medication used regularly
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in VO2Max | 6 weeks (pre-post test) | VO2Max (ml/kg/min) will be measured by indirect gas analysis and compared before and after exercise. |
| Change in Isokinetic Muscle Strength | 6 weeks (pre-post test) | Quadriceps and hamstring strength will be evaluated with an isokinetic dynamometer. |
| Change in Muscle Cross-Sectional Area (CSA) | 6 weeks (pre-post test) | The muscle cross-sectional area (cm²) of the Rectus Femoris will be measured by ultrasound (USG) and its change will be evaluated. |
| Change in Muscle Thickness (MT) | 6 weeks (pre-post test) | The muscle thickness (mm) of the Rectus Femoris will be measured by ultrasound (USG) and its change will be evaluated. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Testosterone Levels | 6 weeks | Blood samples will be collected to measure testosterone levels before and after the intervention. |
| Change in Luteinizing Hormone (LH) Levels | 6 weeks | Luteinizing hormone (LH) levels will be measured with a pre- and post-exercise blood test. |
| Change in Follicle-Stimulating Hormone (FSH) Levels | 6 weeks | Follicle-stimulating hormone (FSH) levels will be measured with a pre- and post-exercise blood test. |
| Change in Dehydroepiandrosterone Sulphate (DHEAS) Levels | 6 weeks | Dehydroepiandrosterone sulphate (DHEAS) levels will be measured with a pre- and post-exercise blood test. |
| Change in Glucose Levels | 6 weeks | Glucose levels will be measured with a pre- and post-exercise blood test. |
| Change in Free Androgen Index (FAI) Levels | 6 weeks | Free androgen index (FAI) levels will be measured with a pre- and post-exercise blood test. |
| Change in BMI (kg/m²) | 6 weeks | — |
| Change in Oxidative Stress and Antioxidant Capacity | 6 weeks | Systemic oxidative stress and total antioxidant capacity will be assessed through blood biomarkers before and after the intervention. |
| Change in Cortisol Levels | 6 weeks | Cortisol levels will be measured with a pre- and post-exercise blood test. |
| Change in Sex Hormone-Binding Globulin (SHBG) Levels | 6 weeks | Sex hormone-binding globulin (SHBG) levels will be measured with a pre- and post-exercise blood test. |
| Change in Creatine Kinase Levels | 6 weeks | Creatine kinase levels will be measured with a pre- and post-exercise blood test. |
| Change in Cholesterol Levels | 6 weeks | Cholesterol levels will be measured with a pre- and post-exercise blood test. |
| Change in Triglyceride Levels | 6 weeks | Triglyceride levels will be measured with a pre- and post-exercise blood test. |
Countries
Turkey (Türkiye)
Outcome results
None listed